BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/24/2022 2:32:33 PM | Browse: 479 | Download: 1270
 |
Received |
|
2021-10-30 04:42 |
|
Peer-Review Started |
|
2021-10-30 04:42 |
|
First Decision by Editorial Office Director |
|
2022-02-14 06:58 |
|
Return for Revision |
|
2022-02-14 06:58 |
|
Revised |
|
2022-03-04 13:33 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-03-22 06:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-03-26 21:45 |
|
Articles in Press |
|
2022-03-26 21:45 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-04-19 09:03 |
|
Publish the Manuscript Online |
|
2022-05-24 14:32 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Case Report |
| Article Title |
Bone flare after initiation of novel hormonal therapy in patients with metastatic hormone-sensitive prostate cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ke-Hao Li, Yuan-Cheng Du, Dong-Yu Yang, Xin-Yuan Yu, Xue-Ping Zhang, Yong-Xiang Li and Liang Qiao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Liang Qiao, MD, PhD, Chief Doctor, Professor, Department of Urology, Weifang People's Hospital, No. 151 Guangwen Street, Kuiwen District, Weifang 261000, Shandong Province, China. lysanjin@163.com |
| Key Words |
Bone flare; Novel hormonal therapy; Metastatic hormone-sensitive prostate cancer; Apalutamide; Case report |
| Core Tip |
In 2018, prostate cancer was ranked as the fifth leading cause of cancer-related deaths in men, worldwide. Some of such cases are metastatic hormone-sensitive prostate cancers (mHSPC) and Apalutamide has been shown to improve survival in such patients. However, a “bone-flare” phenomenon may occur during management with apalutamide. We describe a case of mHSPC with this phenomenon after apalutamide and androgen deprivation therapy, and thus demonstrate the importance of multiple bone imaging modalities, radionuclide bone imaging, magnetic resonance imaging, prostate-specific antigen, prostate-specific membrane antigen positron emission tomography – computed tomography, in determining the treatment course in such patients. |
| Publish Date |
2022-05-24 14:32 |
| Citation |
Li KH, Du YC, Yang DY, Yu XY, Zhang XP, Li YX, Qiao L. Bone flare after initiation of novel hormonal therapy in patients with metastatic hormone-sensitive prostate cancer: A case report. World J Clin Cases 2022; 10(15): 4985-4990 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i15/4985.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i15.4985 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
